N-Acetylcystei ne: Pharmacological Considerations and Experimental and Clinical Applications

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 205-227

  Cotgreave, Ian A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345018815     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60985-0     Document Type: Article

References (122)

1. Abello P.A., Fidler S., and Buchman T.G. Thiol reducing agents modulate TNF-a induced apoptosis in porcine endothelial cells. Shock 2 (1994) 79-83
2. Abrams J. Interactions between organic nitrates and thiol groups. Am. J. Med. 91 (1991) 106-112
3. Albini A., Digostini F., Giunciuglio D., Pagliari I., Balansky R., and De Flora S. Inhibition of invasion, gelatinase activity, tumour take and metastasis of malignant cells by N-acetylcysteine. Int. J. Cancer 61 (1995) 121-129
4. Aruoma O.K., Halliwell B., Hoey B.M., and Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad. Biol. Med. 6 (1989) 593-597
5. Baas P., Oppelaar H., Van Der Valk M.A., Van Zandwijk N., and Stewart F.A. Partial protection of photodynamic-induced skin reactions in mice by N-acetylcysteine: A preclinical study. Photochem. Photobiol. 59 (1994) 448-454
6. Bakker J., Zhang H., Depierreux M., Van Asbeck S., and Vincent J.L. Effects of N-acetyl cysteine in endotoxic shock. J. Crit. Care 9 (1994) 236-243
7. Barreto J.C., Smith G.S., Tornwell M.S., and Miller T.A. Protective action of oral N-acetylcysteine against gastric injury: Role of hypertonic sodium. Am. J. Physiol. 264 (1993) 4422-4426
8. Bast A., Haenen G.R., and Doelrnan M.M.C.J.A. Oxidants and antioxidants: State of art. Am. J. Med. 91 (1991) 2-13
9. Bergelson S., Pinkus R., and Daniel V. Intracellular glutathione levels regulate Fosl Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54 (1994) 36-40
10. Bernard G.R. N-acetylcysteine in experimental and clinical acute lung injury. Am. J. Med. 91 (1991) 54-59
11. Boman G., BÄCker U., Larsson S., Melander B., and Wihlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur. J. Respir. Dis. 64 (1983) 405-415
12. BorgstrÖM L., and KÅGedahl B. Dose-dependent pharmacokinetics of N-acetylcysteine after oral dosing to man. Biopharm. Drug Dispos. 11 (1990) 131-136
13. BorgstrÖM L., KÅGedahl B., and Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur. J. Clin. Pharmacol. 31 (1986) 217-222
14. Bosegaard S., Aldershvile J., Poulsen H.E., Christensen S., Dige-Petersen H., and Giese J. N-acetylcysteine inhibits angiotensin converting enzyme in vivo. J. Pharmacol. Exp. Ther. 265 (1993) 1239-1244
15. Brennan P., and O'Neill L.A. Effect of oxidants and antioxidants on nuclear factor kappa b activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochem. Biophys. Acta 1260 (1995) 167-175
16. Bridgeman M.M.E., Marsden M., Macnee W., Flenley D.C., and Ryle A.P. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 46 (1991) 39-42
17. Burdon R.H., Alliangana D., and Gill V. Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation. Free Rad. Res. 21 (1994) 121-133
18. Burgunder J.M., Varriale A., and Lauterberg B. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur. J. Clin. Pharmacol. 36 (1989) 127-131
19. Cesarone C.F., Scar A Belli L., Giannoni P., and Orunesu M. Differential assay and biological significance of poly(ADP-ribose)-polymerase activity and DNA synthesis in isolated liver nucleii. Mutat. Res. 245 (1992) 157-163
20. Cesarone C.F., Scarabelli L., Orunesu M., Bagnasco M., and De Flora S. Effects of aminothiols in 2-acetylaminofluorene-treated rats. I. Damage and repair of liver DNA, hyperplastic foci and zymbal gland tumours. In Vivo 1 (1987) 85-91
21. Cianfriglia F., Iofrida R.V., Calpicchio A., and Manieri A. The chemoprevention of oral carcinoma with vitamin A and/or N-acetylcysteine. Minetva Stomatol. 43 (1994) 255-261
22. Collart F.R., Horio M., and Huberman E. Heterogeneity in c-jun expression in normal and malignant cells exposed to either ionizing radiation or hydrogen peroxide. Radiat. Res. 142 (1995) 188-196
23. Cotgreave I.A., Berggren M., Jones T.J., Dawson J., and Moldtus P. Castrointestinal metabolism of N-acetylcysteine in the rat, including an assay for sulfite in biological systems. Biopharm. Drug Dispos. 8 (1987) 377-385
24. Cotgreave I.A., Eklund A., Larsson K., and Moldtus P. No penetration of orally administered N-acetylcysteine into bronchalveolar lavage fluid. Eur. J. Respir. Dis. 70 (1987) 73-77
25. Cotgreave I.A., Grafstrom R., and Moldtus P. Modulation of pneumotoxicity by cellular glutathione and precursors. Bull. Eur. Physiopathol. Respir. 22 (1986) 263-266
26. Cotgreave I.A., and Moldtus P. Methodologies for the application of monobromobi- mane to the simultaneous analysis of reduced and oxidised soluble and protein thiol components of biological systems. Biochem. Biophys. Methods 13 (1986) 231-249
27. Cotgreave I.A., and MoldÉUs P. Methodologies for the analysis of reduced and oxidised N-acetylcysteine in biological systems. Biopharm. Drug Dispos. 8 (1987) 365-375
28. Cotgreave I.A., Moldtus P., and Schuppe I. The metabolism of N-acetylcysteine by human endothelial cells. Biochem. Pharmacol. 42 (1991) 13-15
29. Cotgreave I.A., Sandy M.S., Berggren M., Moldtus P.W., and Smith M.T. N-Acetylcysteine and glutathione dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated rat hepatocytes. Biochem. Phamracol. 36 (1987) 2899-2904
30. Das S.K., White A.C., and Fanburg B.L. Modulation of transforming growth factor beta-1 antiproliferative effects on endothelial cells by cysteine, cystine and N-acetylcysteine. J. Clin. Invest. 90 (1992) 1649-1656
31. De Bernardi Di Valserra M., Mautone G., Barindelli E., Lualdi P., Feletti F., and Galmozzi M.R. Bioavailability of suckable tablets of N-acetylcysteine in man. Eur. J. Clin.Phurmacof. 37 (1989) 419-421
32. De Carro L., Ghizzi A., Costa R., Longo A., Ventresca G.P., and Lodola E. Pharmacokinetics and bioavailability of oral N-acetylcysteine in healthy volunteers. Arz-neimettelforschung 39 (1989) 382-386
33. De Flora S., Astengo M., Serra D., and Bennicelli C. Inhibition of urethane-induced lung turnours in mice by N-acetylcysteine. Cancer Lett. 32 (1986) 235-241
34. De Flora S., Izzotti A., D'Agostini F., and Cesarone C.F. Antioxidant activity and other mechanisms of thiols involved in the chemoprevention of mutation and cancer. Am. J. Med. 91 (1991) 122-130
35. DrÖGe W., Eck H.P., Gmilnder H., and Mihm S. Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am. J. Med. 91 (1991) 140-143
36. Eck H.P., Gmunder H., Hartmann M., Ptzoldt D., Daniel V., and DrÖGe W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-infected patients. Biol. Chem. Hoppe-Seyler 370 (1989) 101-108
37. Egawa K., Yoshiwara M., and Nose K. Effect of radical scavengers on TNF alpha-mediated activation of the uPA in cultured cells. Experimentiu 50 (1994) 958-962
38. Esposito F., Cuccovillio F., Morra F., Russo T., and Cimino F. DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in cells. Biochim. Biophys. Acta 1260 (1995) 308-314
39. Eylar E., Rivera-Quinones C., Molina C., Baez I., Molina F., and Mercado C.M. N-actetylcysteine enhances T cell functions and T cell growth in culture. Int. Immunol. 5 (1993) 97-101
40. Fang W., Rivard J.J., Ganser J.A., Lebein T.W., Nath K.A., Mueller D.L., and Behrens T.W. Bcl-XI rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155 (1995) 66-75
41. Faruqi R., De La Motte C., and Dicorleto P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94 (1994) 592-600
42. Ferrari G., Yan C.Y., and Greene L.A. N-acetylcysteine (D- and L-isomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15 (1995) 2857-2866
43. Flescher E., Ledbetter J.A., Schieven G.L., Vela-Roch N., Fossum D., Dang H., Ogawa N., and Talal N. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J. Immunol. 153 (1994) 4880-4889
44. Fung H.L., Chong S., Kowaluk E., Hough K., and Kakemi M. Mechanisms for the phararmacological interactions of organic nitrates with thiols. J. Pharmacol. Exp. Ther. 245 (1988) 524-530
45. Gabard B., and Masher H. Endogenous plasma N-acetylcysteine and single oral dose bioavailability from two different formulations as determined by a new analytical method. Biopharm. Drug Dispos. 12 (1991) 343-353
46. Gressier B., Cabanis A., Lebegue S., Brunet C., Dine T., Luyckx M., Cazin M., and Cazin J.C. Comparison of the in vitro effects of two thiol-containing drugs on human neutrophil hydrogen peroxide production. Meths. Find. Exp. Clin. Pharmacol. 15 (1993) 101-105
47. Hansen N.C., Skriver A., Brorson-Riis L., Balslov S., Evald T., Maltbaek N., Gunnersen G., Garsdal P., Sander P., and Pedersen J.Z. Orally-administered N- acetylcysteine may improve general well being in patients with mild bronchitis. Respir. Med. 88 (1994) 531-535
48. Henderson A., and Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: A potential new use for an old drug. Ann. Pharmacother. 28 (1994) 1086-1088
49. Hockenbury D.M., Oltavi Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl 2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
50. Holdiness M.R. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet. 20 (1991) 123-134
51. Horowitz J.D. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infection. Am. J. Med. 91 (1991) 113-117
52. Huang T.S., Duyster J., and Wang J.Y. Biological response to phorbol ester determined by alternative G1 pathways. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4793-4797
53. Hultberg B., Andersson A., Masson P., Larson M., and Tunek A. Plasma homocyste-ine and thiol compound fractions after oral administration of N-acetylcysteine. Scand. J.Clin. Lab. Invest. 54 (1994) 417-422
54. Huot J., Lambert H., Lavoie J.N., Guidmond A., Houle F., and Landry J. Characterization of a 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat shock protein HSP27. Eur. J. Biochem. 227 (1995) 416-427
55. Imai K., and ToyoÓKa T. Fluorimetric analysis of thiols with fluorobenzoxadiazoles. Methods Enzymol. 143 (1987) 67-75
56. Izzotti A., Balansky R., Scatolini L., Rovida A., and De Flora S. Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke. Carcinogenesis 16 (1995) 669-672
57. Jain A., Buist N.R., Kennaway N.G., Powell B.R., Auld P.A., and Mirtensson J. Effect of ascorbate or N-acetylcysteine treatment in a patient with hereditary glutathione synthetase defficiency. J. Pediatr. 124 (1994) 229-233
58. JÄMstrand C., and ÅKerlund B. Oxygen radical release by neutrophils of HIV infected patients. Chem.-Biol. Interact. 91 (1994) 141-146
59. Jones A.L., Bangash I.H., Bouchier I.A., and Hayes P.C. Portal and systemmic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 35 (1994) 1290-1293
60. KÅGedahl B., and Kallberg M. Determination of non-protein bound N-acetylcysteine in plasma by high performance liquid chromatography. J. Chromatogr. 311 (1982) 170-175
61. Khwali F.A., and Reid M.B. N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro. J. Appl. Physiol. 77 (1994) 317-324
62. Knuckey N.W., Palm D., Primiano M., Epstein L.G., and Johnson C.E. N- Acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke 26 (1995) 305-310
63. Lailey A.F., and Upshall D.G. Thiol levels in rat bronchoalveolar lavage fluid after administration of cysteine esters. Hum. Exp. Toxicol. 13 (1994) 776-780
64. Langley S.C., and Kelly F.J. N-Acetylcysteine ameliorates hyperoxic lung injury in the preterm guinea pig. Biochem. Pharmacol. 45 (1993) 841-846
65. Lewis P.A., Woodward A.J., and Maddock J. Improved method for the determination of N-acetylcysteine in human plasma by high performance liquid chromatography. J. Chromatogr. 327 (1985) 261-267
66. Majima E., Goto S., Hori H., Shinohara Y., Hong Y.M., and Terada H. Stabilities of the fluorescent SH-reagent eosine 5-maleimide and its products with sulphydryl compounds. Biochim. Biophys. Acta 1243 (1995) 336-342
67. Malorini W., Rivaben R., Santini M.T., and Donelli G. N-Acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett.327 (1993) 75-78
68. Malorna W., D'Ambrosia A., Rainaldi G., Rivabene R., and Viora M. Thiol supplier N-acetylcysteine enhances conjugate formation between natural killer cells and K562 or U937 targets but increases the lytic function only against the latter. Immunol. Lett. 43 (1994) 209-214
69. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmed M., Alexander R.W., and Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92 (1993) 1866-1874
70. Meulenbelt J., Van Bree L., Dormans J., and Sangster B. No beneficial effect of N-acetylcysteine treatment on broncho-alveolar lavage fluid variables in acute nitrogen dioxide intoxication in rats. Hum. Exp. Toxicol. 13 (1994) 472-477
71. Meyer A., Buhl R., and Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in ideopathic pulmonary fibrosis. Eur. Respir. J. 7 (1994) 431-436
72. Mihm S., Ennen J., Pessara U., Kurth R., and DrÖGe W. Inhibition of HIV-1 replication and NFKB activity by cysteine and cysteine derivatives. AIDS 5 (1991) 497-503
73. Miquel J., Ferrandiz M.L., De Juan E., Sevila I., and Martinez M. N-Acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. Eur. J. Pharmacol. 292 (1995) 333-335
74. MoldÉUs P. Use of isolated hepatocytes in the study of paracetamol metabolism and toxicity. In: Davis M., Tredger J.M., and Williams R. (Eds). Drug Reactions and the Liver (1981), Pitman Medical, London 114-146
75. MoldÉUs P., Cotgreave I.A., and Berggren M. Lung protection by a thiol containing antioxidant N-acetylcysteine. Respiration 50 (1986) s31-s42
76. Newman C.M., Wassen J.B., Taylor C.W., Boobis A.R., and Davies D.S. Rapid tolerance to the hypotensive effects of glyceryl trinitrate in the rat. Prevention by N-acetyl-L-cysteine but not N-acetybcysteine. Br. J. Pharmacol. 99 (1990) 825 1990
77. Newman G.W., Balcewicz-Sablinsk M.K., Guarnaccia J.R., Remold H.G., and Silberstein D.S. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus. J. Exp. Med. 180 (1994) 359-363
78. Oddera S., Silvestri M., Sacco O., Eftimiadi C., and Rossi G.A. N-Acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J. Lab. Clin. Med. 124 (1994) 293-301
79. Ohman L., Dahlgren C., Follin P., Lew D., and Stendahl O. N-Acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils. Agents Actions 36 (1992) 271-277
80. Olsson B., Johansson M., Gabrielsson J., and Bolme P. Pharmacokinetics and bio-availability of reduced and oxidised N-acetylcysteine. Eur. J. Clin. Pharmacol. 34 (1988) 77-82
81. Parfett C.L., and Pilon R. Oxidative stress-related gene expression and promotion of morphological transformation induced in C3WlOTU2 cells by ammonium metavanadate. Food Chem. Toxicol. 33 (1995) 301-308
82. Peddersen C.O., Barth P., Puchner A., and Von Wichert P. N-Acetylcysteine decreases functional and structural AARDS-typical lung changes in endotoxin-treated rats. Medizini-sche Klinik 88 (1993) 197-206
83. Pendyala L., and Creaven P.J. Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemoprotective agent during a phase I trial. Cancer Epidemiol. Biomark. Prevent. 4 (1995) 245-251
84. Poulsen H.E., Vilstrup H., Almdal T., and Dalhoff K. No net splanchnic release of glutathione in man during N-acetylcysteine infusion. Scand. J. Gastroenterol. 28 (1993) 408-412
85. Prescott L.F. Paracetamol overdosage: Pharmacological considerations and clinical management. Drugs 25 (1983) 290-314
86. Raju P.A., Herzenberg L.A., Herzenberg L.A., and Rooeder M. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxathiazolidine carboxylate compared in in vitro studies of HIV replication. Aids Res. Hum. Retrovir. 10 (1994) 961-967
87. Ratan R.R., Murphy T.H., and Baraban J.M. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14 (1994) 4385-4392
88. Reddy B.S., Rao C.V., Rivenson A., and Kelloff G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res. 53 (1993) 3493-3498
89. Reid M.B., Stokic D.S., Koch S.M., Khwali F.A., and Leis A.A. N-Acetylcysteine inhibits muscle fatigue in humans. J. Clin. Invest. 94 (1994) 2468-2474
90. Reinhart K., Spies C.D., Meier-Hellmann A., Bredle D.L., Hannemann L., Specht M., and Schaffartzik W. N-Acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventillation. Am. J. Respir. Crit. Care Med. 151 (1995) 773-779
91. Riise G.C., Larsson S., Larsson P., Jeansson S., and Andersson B.A. The intrabron-chial microflora in chronic bronchitis patients: A target for N-acetylcysteine therapy? Eur. Respir. J. 7 (1994) 94-101
92. Rizzardini M., Carelli M., Cabello, Porras M.R., and Cantoni L. Mechanism of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: Synergism by glutathione depletion and protection by N-acetylcysteine. Biochem. J. 304 (1994) 477-483
93. Roederer M., Ela S.W., Staal F.J., Herzenberg L.A., and Herzenberg L.A. N-Acetylcysteine: A new approach to anti-HIV therapy. AIDS Res. Hum. Retrovir. 8 (1992) 209-217
94. Roederer M., Raju P.A., Staal F.J., Herzenberg L.A., and Herzenberg L.A. N-Acetylcysteine inhibits latent HIV expression in chronically-infected cells. AIDS Res.Hum. Retrovir. 7 (1991) 563-567
95. Rothstein J.D., Bristol L.A., Hosler B., Brown R.H., and Kuncl R.W. Chronic inhibition of superoxide dismutase produces apoptotic death in spinal neurons. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4155-4159
96. Russel J., Spickett C.M., Geglinski J., Smith W.E., Mcmurray J., and Abdullah I.B. Alterations in erythrocyte glutathione redox balance by N-acetylcysteine, captopril and exogenous glutathione. FEBS Lett. 347 (1994) 215-220
97. Sagara M., Satoh J., Zhu X.P., Takahashi K., Fuzukawa M., Muto G., Muto Y., and Toyota T. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats. Clin. Immunol. Immunopathol. 71 (1994) 333-337
98. SandstrÖM P.A., Mamie M.D., and Buttke T.M. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J. Lekocyte Biol. 55 (1994) 221-226
99. Sandstrom P.A., Roberts B., Folks T.M., and Buttke T.M. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res. Hum. Retrovir. 9 (1993) 1107-1113
100. SÄRnstrand B., Tunek A., Sjcjdin K., and Hallberg A. Effects of n-acetylcysteine stereoisomers on oxygen-induced lung injury in rats. Chem. Biol. Interact. 94 (1995) 157-164
101. Scala R., Moriggi E., Corvasce G., and Morelli D. Protection by N-acetylcysteine against pulmonary endothelial cell damage by oxidant injury. Eur. Respir. J. 6 (1993) 440-446
102. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-Kb transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
103. Sen C.K., Atalay M., and Hanninen O. Excercise-induced oxidative stress: Glutathione supplementation and deficiency. J. Appl. Physiol. 77 (1994) 2177-2187
104. Sen C.K., Rankinen T., Vaisanen S., and Rauramaa R. Oxidative stress after human exercise: Effect of N-acetylcysteine supplementation. J. Appl. Physiol. 76 (1994) 2570-2577
105. Senaldi G., Pointaire P., Piquet P.F., and Grau G.E. Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactions. J. Invest. Dermatol. 102 (1994) 934-937
106. Sheffner A.L. The reduction in vitro in viscocity of muoprotein solutions by a new mucolytic agent, N-acetylcysteine. Ann. N.Y. Acad. Sci. 106 (1963) 298-310
107. SjÖDin K., Nilsson E., Hallberg A., and Tunek A. Metabolism of N-acetylcysteine: Some structural requirements for the deacetylation and consequences for the oral bioavail-ability. Biochem. Pharmacol. 38 (1989) 3981-3985
108. Sohn H.O., Limm H.B., Lee Y.G., Lee D.W., and Kim Y.T. Effect of subchronic administration of antioxidants against cigarette smoke exposure in rats. Arch. Toxicol. 67 (1993) 667-673
109. Spies C.D., Reinhart K., Witt I., Meier-Hellmann A., Hanneman L., Bredle D.L., and Schaff Artzig W. Influence of N-acetylcysteine on direct indicators of tissue oxygen-ation in septic shock patients: Results from a prospective, randomized, double blind study. Crit. Care Med. 22 (1994) 1738-1746
110. Suter P.M., Domenighetti G., Schaller M.D., Laverriere M.C., Ritz R., and Perret C. N-Acetylcysteine enhances recovery from acute lung injury in man: A randomized, double-blind, placebo-controlled clinical study. Chest 105 (1994) 190-194
111. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummulur S., Fine S.M., New D., Epstein L.G., Gendelman H.E., and Gelbard H.A. Tumour necrosis factor-alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes Bcl-2 and crma. Mol. Cell. Biol. 15 (1995) 2359-2366
112. Tang L.D., Sun J.Z., Wu K., Sun C.P., and Tang Z.M. Beneficial effect of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart. Br. J. Pharmacol. 102 (1991) 601-606
113. Thor H., Moldkus P., and Orrenius S. Metabolic activation and hepatotoxicity: Effects of cysteine, N-acetylcysteine, and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes. Arch. Biochem. Biophys. 192 (1979) 405-413
114. ToyÓKa T., and Imai K. High performance liquid chromatography and fluorimetric detection of biologically-important thiols, derivatized with ammonium 7-fluourobenzo- 2-oxa-1,3-diazole-4 sulphonate (SBD-F). I. Chromatogr. 282 (1983) 495-500
115. Van Den Broek L.T., and Beijersbergen Van Hanegouen G.M. Topically-applied N-acetylcysteine as a protector against WB-induced systemic immunosuppression. J. Photochem. Photobiol. B-Biol. 27 (1995) 61-65
116. Vecchiarelli A., Dottorini M., Pietrella D., Cociani C., Eslami A., Todisco T., and Bistoni F. Macrophage activation by N-acetylcysteine in COPD patients. Chest 105 (1994) 806-811
117. Watson W.A., and Mckinney P.E. Activated charcoal and N-acetylcysteine absorb-tion: Issues in interpreting pharmacokinetic data. D.I.C.P. 25 (1991) 1081-1084
118. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heibrock H., and Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor kappa-b mobilization and induction of vascular adhesion molecule-1 in endothelial cells stimulated to produce radicals. Atherosclerosis Thrombosis 14 (1994) 1665-1673
119. Wilpart M., Speder A., and Roberfroid M. Anti-initiation activity of N-acetylcysteine in experimental colonic carcinogenesis. Cancer Lett. 31 (1986) 319-324
120. Witschi A., Junker E., Schranz C., Speck R.F., and Lauterberg B.H. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma from patients with AIDS. AZDS Res. Hum. Retrovir. 11 (1995) 141-143
121. Yoyooka T., Chokshi H.P., Givens R.S., Carlson R.G., Lunte S.M., and Kuwana T. Fluorescent and chemiluminescent detection of oxazole-labelled amines and thiols. Biomed. Chromatog. 7 (1993) 208-216
122. Zamzami N., Marchetti P., Castedo M., Zanin C., Vassiere J.L., Petit P.X., and Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. I. Exp. Med. 181 (1995) 1661-1672